Personalized Medicine Partners (PMP), LLC, is dedicated to empowering pharmaceutical, diagnostic, and biotech companies to successfully develop and commercialize personalized medicine products and services.
Founded by Michael Stocum in 2004, PMP draws on the experience and know-how of its partnership network to provide comprehensive guidance and support at every stage of business and product development. Our capabilities span the continuum of needs from opportunity assessment and strategic planning to tactical activities such as relationship management and project leadership. Clients can access our services through project-based consulting engagements or part-time executive assignments as dictated by the needs of our clients.
Adding Value to Molecular Therapies and Diagnostics
By optimizing planning and execution of a full range of business and product development activities, our integrated approach to consulting delivers tangible results:
- Faster clinical development and commercialization
- Greater product differentiation
- Expanded market reach
- Increased sales revenues
PMP’s services have enabled a wide variety of product developers and service providers to capitalize on the latest advances in biomarker discovery. Through our consulting process, data from biomarker-based research are translated into knowledge that clinicians can use to tailor treatment decisions to individual patients. This approach to establishing clinical utility encourages the growth and acceptance of personalized medicine by demonstrating the potential of individualized therapies and diagnostics to improve health outcomes while reducing costs in major disease areas including:
- infectious diseases
- cardiovascular disease
- metabolic disorders
- critical care
Contact PMP to help you tap into the market potential of personalized medicine. Complete the following form to get started!